(Q39043713)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24335617%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

title

Bortezomib congeners induce apoptosis of hepatocellular carcinoma via CIP2A inhibition (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24335617%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

main subject

hepatocellular carcinoma

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24335617%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Kuen-Feng Chen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24335617%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

author name string

Ann-Chi Huang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24335617%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Chung-Wai Shiau

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24335617%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Chun-Yi Wang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24335617%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Hui-Chuan Yu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24335617%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

language of work or name

English

0 references

publication date

11 December 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24335617%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24335617%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24335617%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24335617%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

page(s)

15398-15411

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24335617%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

3 March 2020

copyright license

start time

11 December 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

CIP2A inhibits PP2A in human malignancies

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES181215398

SV40 small T antigen and PP2A phosphatase in cell transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES181215398

MYC-dependent regulation and prognostic role of CIP2A in gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES181215398

CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES181215398

Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES181215398

CIP2A is a target of bortezomib in human triple negative breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES181215398

Overexpression and small molecule-triggered downregulation of CIP2A in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES181215398

Proteasome inhibitors: antitumor effects and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES181215398

Bortezomib sensitizes HCC cells to CS-1008, an antihuman death receptor 5 antibody, through the inhibition of CIP2A.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES181215398

Synergistic interactions between sorafenib and bortezomib in hepatocellular carcinoma involve PP2A-dependent Akt inactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES181215398

Design, synthesis and biological evaluation of tripeptide boronic acid proteasome inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES181215398

Differential cellular and molecular effects of bortezomib, a proteasome inhibitor, in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES181215398

10.3390/MOLECULES181215398

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24335617%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24335617%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

PubMed publication ID

24335617

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24335617%20AND%20SRC:MED&resulttype=core&format=json